Introduction: eligibility recommendations for competitive athletes with cardiovascular abnormalities-general considerations.
暂无分享,去创建一个
[1] Michael J Ackerman,et al. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. , 2004, Circulation.
[2] Maurizio Schiavon,et al. Does sports activity enhance the risk of sudden death in adolescents and young adults? , 2003, Journal of the American College of Cardiology.
[3] B. Maron. Sudden death in young athletes. , 2003, New England Journal of Medicine.
[4] B. Maron,et al. Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy. , 2003, Journal of the American College of Cardiology.
[5] M. Link,et al. Clinical profile and spectrum of commotio cordis. , 2002, JAMA.
[6] H. Hecht. Recommendations for preparticipation screening and the assessment of cardiovascular disease in masters athletes. , 2001, Circulation.
[7] M. Link,et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.
[8] B. Maron,et al. Prevalence of sudden cardiac death during competitive sports activities in Minnesota high school athletes. , 1998, Journal of the American College of Cardiology.
[9] B. Maron,et al. Competitive athletes with cardiovascular disease--the case of Nicholas Knapp. , 1998, The New England journal of medicine.
[10] F O Mueller,et al. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. , 1996, JAMA.
[11] F O Mueller,et al. Blunt impact to the chest leading to sudden death from cardiac arrest during sports activities. , 1995, The New England journal of medicine.
[12] B. Maron,et al. Legal considerations that affect medical eligibility for competitive athletes with cardiovascular abnormalities and acceptance of Bethesda Conference recommendations. , 1994, Medicine & Science in Sports & Exercise.
[13] P. Raven. 26th Bethesda Conference , 1994 .
[14] B. Maron,et al. Ethical, legal and practical considerations affecting medical decision-making in competitive athletes. , 1994, Journal of the American College of Cardiology.
[15] B. Maron,et al. 26th Bethesda Conferance: Recommendations for determining eligibility for competetion in athletes with cardiovascular abnormalities , 1994 .
[16] B. Maron. Sudden death in young athletes. Lessons from the Hank Gathers affair. , 1993, The New England journal of medicine.
[17] J E Smialek,et al. Sports-related and non-sports-related sudden cardiac death in young adults. , 1991, American heart journal.
[18] J. Mitchell,et al. 16th Bethesda Conference: Cardiovascular abnormalities in the athlete: recommendations regarding eligibility for competition. October 3-5, 1984. , 1985, Journal of the American College of Cardiology.
[19] B. Maron. Hypertrophic cardiomyopathy: an important global disease. , 2004, The American journal of medicine.
[20] M. Mitten. Enhanced Risk of Harm to One's Self as a Justification for Exclusion from Athletics , 1998 .
[21] M. Mitten. Team Physicians and Competitive Athletes: Allocating Legal Responsibility for Athletic Injuries , 1993 .